A case report of hepatorenal syndrome treated with plasma diafiltration (selective plasma filtration with dialysis)

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 5, 2007, Pages 391-395

  Nakae, Hajime ^a   Igarashi, Toshiko ^a   Tajimi, Kimitaka ^a   Kusano, Tomoyuki ^a   Shibata, Satoshi ^a   Kume, Makoto ^a   Sato, Tsutomu ^a   Yamamoto, Yuzo ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatorenal syndrome; Plasma diafiltration; Plasma exchange

Indexed keywords

ALBUMIN; BILIRUBIN; CREATININE; CYSTATIN C; INTERLEUKIN 18;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAFILTRATION; DIALYSIS; HEPATORENAL SYNDROME; HUMAN; MALE; PRIORITY JOURNAL;

AGED; HEMODIAFILTRATION; HEPATORENAL SYNDROME; HUMANS; MALE; PLASMA EXCHANGE;

EID: 34548534539     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00505.x     Document Type: Article

References (15)

1. Nakae H, Yonekawa T, Narita K, Endo S. Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure? Res Commun Mol Pathol Pharmacol 2001 109 : 65 72.
2. Nakae H, Yonekawa C, Wada H, Asanuma Y, Sato T, Tanaka H. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure. Ther Apher 2001 5 : 471 5.
3. Nakae H, Asanuma Y, Tajimi K. Cytokine removal by plasma exchange with continuous hemodiafiltration in critically ill patients. Ther Apher 2002 6 : 419 24.
4. Nakae H, Yonekawa C, Moon S, Tajimi K. The series-parallel circuit in the treatment of fulminant hepatitis. Ther Apher Dial 2004 8 : 153 9.
5. Yonekawa C, Nakae H, Tajimi K, Asanuma Y. Effectiveness of combining plasma exchange and continuous hemodiafiltration in patients with postoperative liver failure. Artif Organs 2005 29 : 324 8.
6. Nakae H, Igarashi T, Tajimi K. The dose of nafamostat mesilate during plasma exchange with continuous hemodiafiltration in the series-parallel circuit. Ther Apher Dial 2006 10 : 233 6.
7. Mori T, Eguchi Y, Shimizu T et al. A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation. Ther Apher 2002 6 : 463 6.
8. Nakae H, Tajimi K. Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane. Ther Apher Dial 2003 7 : 483 5.
9. Kuraray Medical. Evacure Plasmapheresis System. [Cited 29 Jul 2006.] Available from URL: http://www.kuraray.co.jp/Medical
10. Nakae H, Zheng Y-J, Wada H, Tajimi K, Endo S. Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure. Eur Surg Res 2003 35 : 61 6.
11. Newman DJ. Cystatin C. Ann Clin Biochem 2002 39 : 89 104.
12. Shimizu-Tokiwa A, Kobata M, Io H et al. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron 2002 92 : 224 6.
13. Kurtovic J, Boyle M, Bihari D, Riordan SM. An Australian experience with the molecular adsorbents recirculating system (Mars). Ther Apher Dial 2006 10 : 2 6.
14. Evenepoel P, Laleman W, Wilmer A et al. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 2006 30 : 276 84.
15. Rifai K, Manns MP. Review article: clinical experience with Prometheus. Ther Apher Dial 2006 10 : 132 7.